İsteğe bağlı ürün analizi
İzninizle, hangi araştırma yolculuklarının işe yaradığını anlamak için gizliliği gözeten sınırlı analizler kullanırız. Reklam izleyicileri veya oturum kaydı kullanmayız. Bu seçimi Tercihler bölümünden değiştirebilirsiniz. Okuyun Gizlilik Politikası.
JPMorgan Chase & Co.'s published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $953.3B | |
|---|---|---|
| Revenue (ttm) | 190.7B | |
| Net income (ttm) | 64.5B | |
| EPS (ttm) | $23.8 | |
| Shares out | 2.7B | |
| P/E (trailing) | 14.2x | |
| P/E (forward) | 14.5x | |
| Dividend | $6.60 (1.95%) | |
| Volume | 3,608,127 | |
| Beta | 1.02 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $121.65B | $128.70B | $158.10B | $177.56B | $182.45B | +10.7% |
| Gross profit | $130.91B | $121.39B | $145.67B | $158.79B | $167.61B | +6.4% |
| Operating income | $59.56B | $46.17B | $61.61B | $75.08B | $72.60B | +5.1% |
| Net income | $48.33B | $37.68B | $49.55B | $58.47B | $57.05B | +4.2% |
| EPS (diluted) | $15.36 | $12.09 | $16.23 | $19.75 | $20.02 | +6.8% |
| EBITDA | $67.49B | $53.22B | $69.12B | $83.02B | $81.42B | +4.8% |
| R&D | — | — | — | — | — | — |
| SG&A | $38.57B | $41.64B | $46.47B | $51.36B | $54.49B | +9.0% |
Recent company headlines from major financial publishers.
This outcome assumes the earnings reset holds, growth normalizes in FY2027, and the geographic revenue mix remains broadly stable. Results near central FY2027 forecasts would support this outlook.
This outcome requires FY2027 revenue and diluted EPS near the upper ends of their forecast ranges, supported by continued repurchases. Margin erosion or rising diluted shares would disconfirm the outlook by FY2027.
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 6.8% | $326 | $339 | $356 | $377 | $407 |
| 7.8% | $291 | $299 | $308 | $320 | $335 |
| 8.8% | $265 | $270 | $276 | $283 | $291 |
| 9.8% | $244 | $247 | $251 | $255 | $260 |
| 10.8% | $227 | $229 | $231 | $234 | $237 |
Upcoming earnings date and setup when available.
Her ay yayımlanan araştırma sürümünün taşıdığı derecelendirme. Bir derecelendirme, analiz tarihindeki fiyatı gerçeğe uygun değerle karşılaştırır; tahminin doğru çıkıp çıkmadığının kaydı değildir.
| Yıl | Oca | Şub | Mar | Nis | May | Haz | Tem | Ağu | Eyl | Eki | Kas | Ara |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |